Skip to content
akaturk Academic measurement

Academician profile · DOKTOR ÖĞRETİM ÜYESİ

FATMA GİZEM SONUGÜR

ANKARA ÜNİVERSİTESİ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
  • KANSER ARAŞTIRMA ENSTİTÜSÜ
  • TEMEL ONKOLOJİ ANABİLİM DALI
Articles YÖKSİS 9
Projects 1
Books 0
Proceedings 18
Patents 1
Artistic 1
Scopus (SJR)
Q1 2 Q2 4 Q3 2 Q4 1
WoS (JCR)
Q1 1 Q2 4 Q3 3 Q4 1
TR Index 2 articles

Scopus (SJR)

WoS (JCR)

TR Index

2 articles

9 publications total

Articles

  1. 2025 Protective Effects of SIRT2 Inhibition on Cardiac Fibrosis The Anatolian Journal of Cardiology DOI 10.14744/anatoljcardiol.2025.4770
  2. 2024 AGK2, a SIRT2 inhibitor, ameliorates D‐galactose‐induced liver fibrosis by inhibiting fibrogenic factors Journal of Biochemical and Molecular Toxicology DOI 10.1002/jbt.70000
  3. 2023 Protective Effect of Pharmacological SIRT2 Inhibition on Renal Dysfunction, Fibrosis, TGF-β1/β-Catenin, and Klotho Signaling in D-Galactose-Induced Aging Model JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS DOI 10.23812/j.biol.regul.homeost.agents.20233711.580
  4. 2023 The effects of anti-PD-L1 monoclonal antibody on the expression of angiogenesis and invasion-related genes TURKISH JOURNAL OF BIOLOGY DOI 10.55730/1300-0152.2661
  5. 2023 Incubation Temperature and Period During Denarase Treatment and Microfiltration Affect the Yield of Recombinant Adenoviral Vectors During Downstream Processing MOLECULAR BIOTECHNOLOGY DOI 10.1007/s12033-022-00616-8
  6. 2019 The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors Frontiers in Genetics DOI 10.3389/fgene.2019.01063
  7. 2018 The effects of melatonin and curcumin on the expression of SIRT2, Bcl-2 and Bax in the hippocampus of adult rats Brain Research Bulletin DOI 10.1016/j.brainresbull.2018.01.006
  8. 2016 A novel fluorescence turn-on coumarin-pyrazolone based monomethine probe for biothiol detection Tetrahedron DOI 10.1016/j.tet.2016.06.008
  9. 2016 The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC) ANNALS OF ONCOLOGY DOI 10.1093/annonc/mdw392.34

Back to academicians